In this narrative review, we discuss pharmacological therapeutic options for MASH with a focus on newly approved or promising metabolism-based pharmacotherapies currently being evaluated in late-phase RCTs for the treatment of this common and burdensome liver disease
The use of prazosin, an 1-adrenergic receptor blocker, showed that the ability of GLP-1RAs to reduce TNF- in plasma was disrupted, signifying the vital role of 1-adrenergic receptors in the anti-inflammatory action of GLP-1RAs
And without the continued downward trajectory that motivated continued use, exploring alternatives with different mechanisms becomes an appealing strategy to break through stalled progress
Sandra was truly outstanding, friendly, kind, and gentle in every aspect of her work
Clinical impacts of sun exposures on the faces and hands of Japanese women of different ages
Safe and Effective Treatments TrimRx prioritizes safety and effectiveness by involving licensed healthcare providers in every step of the process